I share your pain Figgs and I hope Evil is right about the partnership.
I also understand your frustration about trials, but we can barely afford employee salaries let alone start new trials.
I think Cyrus was hallucinating about starting trials later next year. I personally think he should sell or even liquidate at this point.
Sorry, but don’t tell me that BPs are dumb, and just sitting there looking at us having a miraculous drug and not doing anything to acquire for cheap, dirt cheap. So far, the most charismatic people about this drug are its investors. We have not seen otherwise.
Hope this changes…